| Product Code: ETC6749168 | Publication Date: Sep 2024 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Dhaval Chaurasia | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 China Oncology NGS Market Overview |
3.1 China Country Macro Economic Indicators |
3.2 China Oncology NGS Market Revenues & Volume, 2021 & 2031F |
3.3 China Oncology NGS Market - Industry Life Cycle |
3.4 China Oncology NGS Market - Porter's Five Forces |
3.5 China Oncology NGS Market Revenues & Volume Share, By Technology, 2021 & 2031F |
3.6 China Oncology NGS Market Revenues & Volume Share, By Application, 2021 & 2031F |
3.7 China Oncology NGS Market Revenues & Volume Share, By Service, 2021 & 2031F |
3.8 China Oncology NGS Market Revenues & Volume Share, By Workflow, 2021 & 2031F |
3.9 China Oncology NGS Market Revenues & Volume Share, By End-use, 2021 & 2031F |
4 China Oncology NGS Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing incidence of cancer in China |
4.2.2 Growing adoption of precision medicine in oncology |
4.2.3 Technological advancements in next-generation sequencing (NGS) technologies |
4.3 Market Restraints |
4.3.1 High cost associated with oncology NGS testing |
4.3.2 Lack of reimbursement policies for NGS testing in China |
4.3.3 Data privacy and security concerns regarding genomic data |
5 China Oncology NGS Market Trends |
6 China Oncology NGS Market, By Types |
6.1 China Oncology NGS Market, By Technology |
6.1.1 Overview and Analysis |
6.1.2 China Oncology NGS Market Revenues & Volume, By Technology, 2021- 2031F |
6.1.3 China Oncology NGS Market Revenues & Volume, By Whole Genome Sequencing, 2021- 2031F |
6.1.4 China Oncology NGS Market Revenues & Volume, By Whole Exome Sequencing, 2021- 2031F |
6.2 China Oncology NGS Market, By Application |
6.2.1 Overview and Analysis |
6.2.2 China Oncology NGS Market Revenues & Volume, By Diagnostics and Screening, 2021- 2031F |
6.2.3 China Oncology NGS Market Revenues & Volume, By Research Studies, 2021- 2031F |
6.3 China Oncology NGS Market, By Service |
6.3.1 Overview and Analysis |
6.3.2 China Oncology NGS Market Revenues & Volume, By Platforms and Related Products, 2021- 2031F |
6.3.3 China Oncology NGS Market Revenues & Volume, By Services, 2021- 2031F |
6.4 China Oncology NGS Market, By Workflow |
6.4.1 Overview and Analysis |
6.4.2 China Oncology NGS Market Revenues & Volume, By Pre-Sequencing, 2021- 2031F |
6.4.3 China Oncology NGS Market Revenues & Volume, By Sequencing, 2021- 2031F |
6.4.4 China Oncology NGS Market Revenues & Volume, By NGS Data Analysis, 2021- 2031F |
6.5 China Oncology NGS Market, By End-use |
6.5.1 Overview and Analysis |
6.5.2 China Oncology NGS Market Revenues & Volume, By Academic Research, 2021- 2031F |
6.5.3 China Oncology NGS Market Revenues & Volume, By Clinical Research, 2021- 2031F |
6.5.4 China Oncology NGS Market Revenues & Volume, By Hospitals & Clinics, 2021- 2031F |
6.5.5 China Oncology NGS Market Revenues & Volume, By Pharma & Biotech Entities, 2021- 2031F |
6.5.6 China Oncology NGS Market Revenues & Volume, By Other users, 2021- 2031F |
7 China Oncology NGS Market Import-Export Trade Statistics |
7.1 China Oncology NGS Market Export to Major Countries |
7.2 China Oncology NGS Market Imports from Major Countries |
8 China Oncology NGS Market Key Performance Indicators |
8.1 Average turnaround time for NGS testing |
8.2 Rate of adoption of NGS in oncology clinics |
8.3 Number of collaborations between NGS technology providers and healthcare institutions |
9 China Oncology NGS Market - Opportunity Assessment |
9.1 China Oncology NGS Market Opportunity Assessment, By Technology, 2021 & 2031F |
9.2 China Oncology NGS Market Opportunity Assessment, By Application, 2021 & 2031F |
9.3 China Oncology NGS Market Opportunity Assessment, By Service, 2021 & 2031F |
9.4 China Oncology NGS Market Opportunity Assessment, By Workflow, 2021 & 2031F |
9.5 China Oncology NGS Market Opportunity Assessment, By End-use, 2021 & 2031F |
10 China Oncology NGS Market - Competitive Landscape |
10.1 China Oncology NGS Market Revenue Share, By Companies, 2024 |
10.2 China Oncology NGS Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here